Sort
82,697 grants matching “vaccine development”
Identification of GP38 and NP antibodies and their protective mechanisms against CCHFV
$738,880Scott Dusan Pegan · University Of California Riverside · R01 · FY2025 · AI
Development of an RSV vaccine for the elderly
$738,847Trudy G. Morrison · Univ Of Massachusetts Med Sch Worcester · R01 · FY2020 · AI
The effect of binding of fH to meningococcal fHbp vaccine on antibody protection
$738,843Dan M. Granoff · Children'S Hospital & Res Ctr At Oakland · R01 · FY2015 · AI
Urban Water Systems, Enteric Pathogen Distribution & Gut Microbiome Development in Children: A Natural Experiment in Mozambique
$738,842Matthew C Freeman · Emory University · R01 · FY2020 · AI
Structure-based design of broad flavivirus immunogens
$738,795Jonathan R. Lai · Albert Einstein College Of Medicine · R01 · FY2025 · AI
Structure-based design of broad flavivirus immunogens
$738,795Jonathan R. Lai · Albert Einstein College Of Medicine · R01 · FY2024 · AI
Structure-based design of broad flavivirus immunogens
$738,795Jonathan R. Lai · Albert Einstein College Of Medicine · R01 · FY2023 · AI
Structure-based design of broad flavivirus immunogens
$738,795Jonathan R. Lai · Albert Einstein College Of Medicine · R01 · FY2022 · AI
RFA-IP-22-004, Modeling toolkit to evaluate multifaceted control strategies for seasonal and pandemic influenza
$738,731Lauren Ancel Meyers · University Of Texas At Austin · U01 · FY2023 · IP
Modeling toolkit to evaluate multifaceted control strategies for seasonal and pandemic influenza
$738,730Lauren Ancel Meyers · University Of Texas At Austin · U01 · FY2022 · IP
Leveraging Community-Academic Partnerships and Social Networks to Disseminate Vaccine-Related Information and Increase Vaccine Uptake Among Black Individuals with Rheumatic Diseases
$738,723Rosalind Ramsey-Goldman · Northwestern University At Chicago · R01 · FY2023 · AR
CMV-specific CD19 CAR T cells amplified in vivo using CMV Triplex vaccine for B-NHL
$738,698Xiuli Wang · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA
Innate-adaptive crosstalk in protective and vaccine-induced immunity to TB
$738,657Jyothi Rengarajan · Emory University · R01 · FY2019 · AI
Administration
$738,644Ronald B Corley · Boston University Medical Campus · UC7 · FY2023 · AI
Nonhuman Primate (NHP) Core B
$738,635Michael K Axthelm · Oregon Health & Science University · U19 · FY2021 · AI
Aberrant immune activation in the tuberculosis granuloma: a pivotal role in necrosis
$738,628Igor Kramnik · Boston University Medical Campus · R01 · FY2019 · HL
Aberrant immune activation in the tuberculosis granuloma: a pivotal role in necrosis
$738,628Igor Kramnik · Boston University Medical Campus · R01 · FY2018 · HL
A Phylodynamic Artificial Intelligence framework to predict evolution of SARS-CoV-2 variants of concern in Immunocompromised persons with HIV (PhAI-CoV)
$738,604Marco Salemi · University Of Florida · R01 · FY2024 · AI
In vivo engineering of B cells for the secretion of HIV broadly neutralizing antibodies
$738,581James Even Voss · Scripps Research Institute, The · R01 · FY2023 · AI
Evolution of anti-filovirus B cell responses and mechanisms of protection
$738,574M. Javad Aman · Integrated Biotherapeutics, Inc. · R01 · FY2020 · AI
Launching HBV with RNA to assess antiviral resistance and explore fundamental aspects of virus-host biology
$738,557Charles M. Rice · Rockefeller University · R01 · FY2025 · AI
Sex determination and the sex-determining locus in aedine mosquitoes
$738,552Zhijian Jake Tu · Virginia Polytechnic Inst And St Univ · R01 · FY2024 · AI
The Evaluation of Novel Therapeutics for Genitourinary Malignancies
$738,484William Laurence Dahut · Division Of Clinical Sciences - Nci · ZIA · FY2015 · CA
Immunity to Cryptosporidium
$738,461Boris Striepen · University Of Pennsylvania · R01 · FY2020 · AI
Multivalent mRNA-based malaria vaccines
$738,445James Matthew Burns · Drexel University · R01 · FY2024 · AI